Immune banking

Biobanking of the human samples to support translational research is a global movement and is now being well established across all continents. Major challenges lie in the fact on how to obtain; process and supply samples to support research projects. Biobanking activities overlap with the Anatomical Pathology activities. Collection, embedding, sectioning and storing of collected samples are done daily. All samples are provided to the researcher with the de-identified path report and verification. Researchers usually concentrate on gene expression techniques. When it comes to protein expression in the tissue, immunohistochemistry is method performed. Diagnostic laboratories perform routine immunohistochemistry on a large number of more commonly used antibodies such AE1/AE3; CD45;ER/PR/Her2. Diagnostic laboratories have no spare time that is required to standardize and optimize novel antibodies which researchers are applying in their study. This is the point where we are able to offer support and utilize resources with a dual benefit. We have been optimizing anti NR1D1 (nuclear receptor for squamous cell carcinoma) for thyroid study; caspase 3, 8 and 9 (cell apoptosis) in breast cancer study; F4/80 in mouse model for macrophage/inflammation detection just to mention few. We support research work and continue to learn more about possibilities of immunohistochemistry. All slides obtained are scanned to get digital image. All results obtained from immunohistochemistry are interpreted by anatomical pathologist.

Genomic Sample Prep and Biomarker Assay Development San Francisco, USA, Cancer Immunotherapy San Francisco, USA, Biomarkers for Cancer Immunotherapy San Francisco, USA, Biomarkers & Diagnostics World Congress Philadelphia, USA, Keystone Cardiac Development, Regeneration and Repair (Z2) Snowbird, Utah, USA, The Stem Cell Niche–Development & Disease Hillerød, Denmark, Molecular and Cellular Basis of Growth and Regeneration (A3) Breckenridge, Colorado, USA, Phacilitate Cell & Gene Therapy World Washington D.C., USA, Germline Stem Cells Conference, Abcam meeting before ISSCR San Francisco, California, USA, World Conference on Regenerative Medicine 2015 Leipzig, Germany.

According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver for biobanks, hospitals and gene banks, which are the major end-user segments of the biopreservation media & equipment market.

Biobanking of the human samples to support translational research is a global movement and is now being well established across all continents. Major challenges lie in the fact on how to obtain; process and supply samples to support research projects. Biobanking activities overlap with the Anatomical Pathology activities. Collection, embedding, sectioning and storing of collected samples are done daily. All samples are provided to the researcher with the de-identified path report and verification. Researchers usually concentrate on gene expression techniques. When it comes to protein expression in the tissue, immunohistochemistry is method performed. Diagnostic laboratories perform routine immunohistochemistry on a large number of more commonly used antibodies such AE1/AE3; CD45; ER/PR/Her2. Diagnostic laboratories have no spare time that is required to standardize and optimize novel antibodies which researchers are applying in their study. This is the point where we are able to offer support and utilize resources with a dual benefit. We have been optimizing anti NR1D1 (nuclear receptor for squamous cell carcinoma) for thyroid study; caspase 3, 8 and 9 (cell apoptosis) in breast cancer study; F4/80 in mouse model for macrophage/inflammation detection just to mention few. We support research work and continue to learn more about possibilities of immunohistochemistry. All slides obtained are scanned to get digital image. All results obtained from immunohistochemistry are interpreted by anatomical pathologist.

  • Fundamental mechanism of Ag detection
  • Stem cell cancer detection Marker
  • Type of Tumor identification
  • Assessment of NRAS mutation

Related Conference of Immune banking

Immune banking Conference Speakers